Sigma-1 受体激活减轻心脏缺血再灌注损伤

doi:10.12066/j.issn.1007-2861.2096

摘要/Abstract

摘要：

[目的] 研究 sigma-1 受体的激活与抑制对心脏缺血再灌注损伤的作用. [方法] C57BL/6 小鼠经过 3 d 尾静脉注射 sigma-1 受体抑制剂 BD1047, sigma-1 受体激动剂 SA4503 或生理盐水后施行心脏缺血再灌注手术. 术后对小鼠心脏进行 TTC/Evans 蓝双染色并计算心脏梗死区 (infarction area, INF) 与危险区 (area at risk, AAR) 比值(INF/AAR), 同时对心肌组织采用蛋白免疫印迹法检测凋亡相关蛋白 Bcl-2, Bax, Caspase-3 的表达水平. [结果] 接受了 sigma-1 受体抑制剂 BD1047 预处理的小鼠, 其 INF/AAR 值远大于对照组 ($P\!<$0.05), 心肌组织中促凋亡相关蛋白的表达水平升高, 抗凋亡相关蛋白的表达水平降低. 而接受 sigma-1 受体激动剂 SA4503 预处理的小鼠, 其 INF/AAR 值远小于对照组 ($P\!<$0.05), 心肌组织中促凋亡相关蛋白的表达水平降低, 抗凋亡相关蛋白的表达水平升高. [结论] Sigma-1 受体的激活能够改善心脏缺血再灌注损伤, 而抑制 sigma-1 受体则会加重心脏缺血再灌注损伤.

关键词: Sigma-1受体, 心肌梗死, 缺血再灌注损伤

Abstract:

[Objective] This paper attempts to investigate whether sigma-1 receptor (Sig1R) activation attenuate myocardial ischemia reperfusion injury (MIRI) and whether Sig1R inhibition exacerbates MIRI in mice model. [Methods] C57BL/6 mice are injected via tail vein with BD1047 (Sig1R inhibitor), SA4503 (Sig1R activator) or saline 3 days before MIRI surgery. Then, double-staining technique and western blot analysis are performed on myocardium tissue. [Results] Mice that have received BD1047 pretreatment demonstrate a significant increase in the myocardial infarction size after I/R compared with control group ($P\!\!<$0.05), and a significantly increased expression of Bax and Caspases-3 proteins and a significantly reduced expression of Bcl-2 protein compared with sham control, MIRI control and sham BD1047 groups ($P\!<$0.05). Mice that have received SA4503 pretreatment demonstrate a significant reduction in myocardial infarction size after I/R compared with control group ($P\!<$0.05), and a significantly reduced expression of Bax and cleaved Caspases-3 proteins and a significantly increased expression of Bcl-2 protein compared with sham control, MIRI control and sham SA4503 groups ($P\!<$0.05). [Conclusions] SA4503 protects MIRI and reduces myocardial infarction whereas BD1047 deteriorates MIRI and augment myocardial infarction, and these effects may be achieved through activation or inhibition of Sig1R.

Key words: Sigma-1 receptor, mycardial infarction, ischemia reperfusion injury

中图分类号:

R541.4

廖小平, 喻溥蛟, 许嘉鸿. Sigma-1 受体激活减轻心脏缺血再灌注损伤[J]. 上海大学学报(自然科学版), 2018, 24(6): 853-860.

LIAO Xiaoping, YU Pujiao, XU Jiahong. Effectiveness of activation of sigma-1 receptor on reducing myocardium injury in ischemia reperfusion[J]. Journal of Shanghai University（Natural Science Edition）, 2018, 24(6): 853-860.

图/表 4

参考文献 31

[1]	Yellon D M, Hausenloy D J. Myocardial reperfusion injury[J]. N Engl J Med, 2007,357:1121-1135. doi: 10.1056/NEJMra071667 pmid: 17855673
[2]	Hausenloy D J, Yellon D M. Targeting myocardial reperfusion injury: the search continues[J]. N Engl J Med, 2015,373:1073-1075. pmid: 26321104
[3]	Hausenloy D J, Yellon D M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target[J]. J Clin Invest, 2013,123:92-100.
[4]	IbÁÑez B, Heusch G, Ovize M, et al. Evolving therapies for myocardial ischemia/reperfusion injury[J]. J Am Coll Cardiol, 2015,65:1454-1471.
[5]	Lejay A, Fang F, John R, et al. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus[J]. Journal of Molecular and Cellular Cardiology, 2016,91:11-22.
[6]	Hayashi T, Su T P. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca²⁺ signaling and cell survival [J]. Cell, 2007,131:596-610. pmid: 17981125
[7]	Su T P, Hayashi T, Maurice T, et al. The sigma-1 receptor chaperone as an inter-organelle signaling modulator[J]. Trends Pharmacol Sci, 2010,31:557-566. doi: 10.1016/j.tips.2010.08.007 pmid: 20869780
[8]	Fujimoto M, Hayashi T, Urfer R, et al. Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor[J]. Synapse, 2012,66:630-639. doi: 10.1002/syn.21549 pmid: 22337473
[9]	Meunier J, Hayashi T. Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of NF$\kappa$B[J]. J Pharmacol Exp Ther, 2010,332:388-397. pmid: 19855099
[10]	Tsai S Y, Hayashi T, Mori T, et al. Sigma-1 receptor chaperones and diseases[J]. Cent Nerv Syst Agents Med Chem, 2009,9:184-189. doi: 10.2174/1871524910909030184 pmid: 20021352
[11]	Klouz A, SaÏd D B, Ferchichi H, et al. Protection of cellular and mitochondrial functions against liver ischemia by $N$-benzyl-$N$'-(2-hydroxy-3,4-dimethoxybenzyl)-piperazine (BHDP), a sigma1 ligand[J]. Eur J Pharmacol, 2008,578(2/3):292-299.
[12]	Hosszu A, Antal Z, Lenart L, et al. $\sigma $1-receptor agonism protects against renal ischemia-reperfusion injury[J]. J Am Soc Nephrol, 2017,28(1):152-165. doi: 10.1681/ASN.2015070772 pmid: 27056295
[13]	Bucolo C, Drago F. Neuroactive steroids protect retinal tissue through $\sigma $1 receptors[J]. Basic Clin Pharmacol Toxicol, 2007,100:214-216. doi: 10.1111/j.1742-7843.2007.00044.x pmid: 17309527
[14]	Shen Y C, Wang Y H, Chou Y C, et al. Dimemorfan protects rats against ischemic stroke through activation of sigma-1 receptor-mediated mechanisms by decreasing glutamate accumulation[J]. J Neurochem, 2008,104:558-572. doi: 10.1111/j.1471-4159.2007.05058.x pmid: 18173806
[15]	Tagashira H, Zhang C, Lu Y M, et al. Stimulation of $\sigma $1-receptor restores abnormal mitochondrial Ca²⁺ mobilization and ATP production following cardiac hypertrophy [J]. Biochim Biophys Acta, 2013,1830:3082-3094. doi: 10.1016/j.bbagen.2012.12.029 pmid: 23298811
[16]	Tagashira H, Bhuiyan M S, Shioda N, et al. Fluvoxamine rescues mitochondrial Ca²⁺ transport and ATP production through $\sigma $1-receptor in hypertrophic cardiomyocytes [J]. Life Sci, 2014,95:89-100. pmid: 24373833
[17]	Bhuiyan M S, Fukunaga K. Stimulation of sigma-1 receptor signaling by dehydroepiandrosterone ameliorates pressure overload-induced hypertrophy and dysfunctions in ovariectomized rats[J]. Expert Opin Ther Targets, 2009,13:1253-1265. pmid: 19769544
[18]	Bhuiyan M S, Tagashira H, Fukunaga K. Dehydroepiandrosterone mediated stimulation of sigma-1 receptor activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding[J]. Cardiovasc Ther, 2010,29:219-230. doi: 10.1111/j.1755-5922.2010.00196.x pmid: 20553277
[19]	Bhuiyan M S, Tagashira H, Fukunaga K. Sigma-1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding[J]. Eur J Pharmacol, 2011,650:621-628. doi: 10.1016/j.ejphar.2010.10.055 pmid: 21044620
[20]	Ito K, Hirooka Y, Matsukawa R, et al. Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression[J]. Cardiovas Res, 2012,93:33-40.
[21]	Dumont E A, Hofstra L, Van Heerde W L, et al. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-Ⅴ in a mouse model[J]. Circulation, 2000,102:1564-1568. pmid: 11004148
[22]	Dumont E A, Reutelingsperger C P, Smits J F, et al. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart[J]. Nature Medicine, 2001,7(12):1352-1355. doi: 10.1038/nm1201-1352 pmid: 11726977
[23]	Whelan R S, Kaplinskiy V, Kitsis R N. Cell death in the pathogenesis of heart disease: mechanisms and significance[J]. Annu Rev Physiol, 2010,72:19-44. doi: 10.1146/annurev.physiol.010908.163111 pmid: 20148665
[24]	Hausenloy D J, Yellon D M. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion[J]. J Mol Cell Cardiol, 2003,35:339-341. doi: 10.1016/s0022-2828(03)00043-9 pmid: 12689812
[25]	Ong S B, Samangouei P, Kalkhoran S B, et al. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury[J]. J Mol Cell Cardiol, 2015,78:23-34. pmid: 25446182
[26]	Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium[J]. Circ Res, 1996,79:949-956. doi: 10.1161/01.res.79.5.949 pmid: 8888687
[27]	Di Lisa F, Canton M, Menabo R, et al. Mitochondria and reperfusion injury: the role of permeability transition[J]. Basic Res Cardiol, 2003,98:235-241. doi: 10.1007/s00395-003-0415-x pmid: 12835952
[28]	Halestrap A P, Richardson A P. The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury[J]. J Mol Cell Cardiol, 2015,78:129-141. doi: 10.1016/j.yjmcc.2014.08.018 pmid: 25179911
[29]	Eltzschig H K, Eckle T. Ischemia and reperfusion: from mechanism to translation[J]. Nat Med, 2011,17:1391-1401. pmid: 22064429
[30]	Shimazawa M, Sugitani S, Inoue Y, et al. Effect of a sigma-1 receptor agonist, cutamesine dihydrochloride (SA4503), on photoreceptor cell death against light-induced damage[J]. Exp Eye Res, 2015,132:64-72. doi: 10.1016/j.exer.2015.01.017 pmid: 25616094
[31]	Urfer R, Moebius H J, Skoloudik D, et al. Cutamesine stroke recovery study group. Phase Ⅱ trial of the sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke[J]. Stroke, 2014,45:3304-3310. doi: 10.1161/STROKEAHA.114.005835 pmid: 25270629